Moderna continues to cut costs, which could raise questions about the vaccine playbook used during the Covid-19 pandemic.

Stock photo of a syringe. Experts are urging the Biden administration to approve a vaccine for the H5N1 bird flu virus. Stock photo of a syringe. Experts are urging the Biden administration to ...

Vaccine vial of H5N1 in a bottle with a syringe on a blue background. There are several licensed vaccines for avian influenza in poultry, but their use has not been authorized in the U.S. during ...

Although a candidate bird flu vaccine has not yet been made commercially available, medical experts advise that people should get it once it is. Dr. Linda Yancey, an expert in infectious ...

Last week’s newsletter on the Biden administration’s refusal to approve updated bird flu vaccines before the president left office prompted many reader questions, which I wanted to address here.

For months, top scientists, including former government officials appointed by presidents Joe Biden and Barack Obama, have called on the outgoing administration to make bird flu vaccines available ...

Erica Denhoff / Icon Sportswire via Getty Images Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech ...

There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...

TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...